Related Experiment Video
Updated: Jul 31, 2026

Intracranial Injection of Adeno-associated Viral Vectors
Published on: November 17, 2010
Case Report: Acute Necrotizing Encephalopathy Following COVID-19 Vaccine
Mohamed Reda Bensaidane1, Vincent Picher-Martel1,2, François Émond1
1Department of Medicine, Faculty of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, QC, Canada.
Objectives:
Acute necrotizing encephalopathy (ANE) is a rare neurological disorder arising from a para- or post-infectious "cytokine storm. "It has recently been reported in association with coronavirus disease 2019 (COVID-19) infection.
Methods:
A 56-year-old male with a diagnosis of ANE 48 h following the first dose of ChAdOx1 nCoV-19 vaccination was investigated. Cytokine analyses on serum and cerebrospinal fluid (CSF) were performed. The patient was treated with high-dose corticosteroids and followed clinically and radiologically.
Results:
Favorable clinical and radiological outcomes were noted. There was an upregulation in serum levels of CXCL5, CXCL1, Il-8, IL-15, CCL2, TGF-B, and EGF, and up-regulation in CSF levels of CXCL5, IL-2, IL-3, and IL-8.
Discussion:
As COVID-19 infection has been previously reported as a possible rare cause of ANE, we speculate on an aberrant immune response mechanism that was brought about by the vaccine. To increase our understanding of the pathogenesis of ANE in the context of COVID-19 vaccination and to better define its clinical features and outcomes, clinicians and scientists should continue reporting convincing cases of such entities.
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Cryptococcal Meningitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Hepatic Encephalopathy

